Cicero 2004a.
Clinical features and settings | High‐risk referral for invasive testing | |
Participants | 970 fetuses (20 twin and 1 triplet pregnancy) UK Dates not specified Pregnant women Median age 37 years (16‐48 years) 11‐14 weeks' gestation (median 12 weeks) |
|
Study design | Prospective cohort study | |
Target condition and reference standard(s) | Down's syndrome: 88 cases Reference standard: CVS |
|
Index and comparator tests | Maxillary bone length Mid‐saggital view of fetal profile obtained for nasal bone. Transducer angled laterally so that the maxillary bone and mandible including the ramus and condylar process can be seen. Maxillary length measured with callipers. Magnified to 0.1 mm increment |
|
Follow‐up | 100% karyotyping | |
Aim of study | To determine the value of measuring maxillary length at 11‐14 weeks' gestation in screening for trisomy 21 | |
Notes | ||
Table of Methodological Quality | ||
Item | Authors' judgement | Description |
Representative spectrum? All tests | Yes | Selective testing of high‐risk women as done in practice |
Acceptable reference standard? All tests | Yes | CVS |
Partial verification avoided? All tests | Yes | All women had a reference standard |
Differential verification avoided? All tests | Yes | All women had the same reference standard |
Incorporation avoided? All tests | Yes | Reference standard was independent of the index test |
Reference standard results blinded? All tests | No | Reference standard interpreted with knowledge of index test results |
Index test results blinded? All tests | Yes | Index test interpreted without knowledge of reference standard results |
Relevant clinical information? All tests | Yes | Information available as would be in standard clinical practice |
Uninterpretable results reported? All tests | Yes | Study reports that measurements were made successfully in all cases |
Withdrawals explained? All tests | No | No details of withdrawals given |